Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EBITDA (2024 - 2025)

Historic EBITDA for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$31.8 million.

  • Kestra Medical Technologies' EBITDA fell 6596.11% to -$31.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$129.4 million, marking a year-over-year decrease of 6625.48%. This contributed to the annual value of -$106.4 million for FY2025, which is 2505.79% down from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' EBITDA is -$31.8 million, which was down 6596.11% from -$28.9 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year EBITDA high stood at -$18.4 million for Q3 2024, and its period low was -$48.2 million during Q2 2025.